{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:04:42Z","timestamp":1790971482587,"version":"4.1.0"},"reference-count":226,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008902","name":"Los Alamos National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Chronic inflammatory gastrointestinal disorders, including inflammatory bowel disease (IBD), Crohn\u2019s disease, ulcerative colitis, and irritable bowel syndrome (IBS), remain challenging to manage due to complex etiologies, heterogeneous disease progression, and limitations in current diagnostic and therapeutic strategies. Existing clinical approaches rely on a combination of invasive and non-invasive diagnostic tools, while therapeutic management predominantly involves symptomatic control, disease-modifying pharmacotherapy, and surgical interventions. However, these strategies often fail to enable early or real-time disease detection and frequently fall short of achieving sustained remission. This review highlights two emerging and potentially transformative approaches: nanomedicine and living diagnostic\u2013therapeutic systems. Nanomedicine has gained significant attention for its ability to enhance targeted drug delivery and improve therapeutic efficiency, addressing several limitations of conventional treatments; nevertheless, challenges related to delivery consistency, biosafety, scalability, and long-term efficacy persist. In parallel, living diagnostic\u2013therapeutic systems\u2014engineered whole-cell sensors capable of real-time sensing and on-demand therapeutic response within the gut\u2014represent a compelling alternative. Although still at an early stage of development, promising preclinical and limited clinical studies demonstrate their potential utility. Key challenges remain, including biosensor functionality, genetic stability, microbial colonization, host\u2013microbe interactions, and integration into existing healthcare frameworks, alongside regulatory and translational barriers. Overall, the convergence of nanomedicine and living, responsive systems may offer a transformative pathway for the diagnosis and treatment of chronic inflammatory gut diseases.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1762119","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:58:15Z","timestamp":1772607495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Current and emerging approaches to manage chronic inflammatory gut disorders"],"prefix":"10.3389","volume":"16","author":[{"given":"Katelyn M.","family":"Green","sequence":"first","affiliation":[{"name":"Microbial and Biome Sciences Group (B-IOME), Bioscience Division, Los Alamos National Laboratory","place":["Los Alamos, NM, United States"]},{"name":"Nuclear & Radiochemistry Group (C-NR), Chemistry Division, Los Alamos National Laboratory","place":["Los Alamos, NM, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Min","family":"Shin","sequence":"additional","affiliation":[{"name":"Microbial and Biome Sciences Group (B-IOME), Bioscience Division, Los Alamos National Laboratory","place":["Los Alamos, NM, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh K.","family":"Jha","sequence":"additional","affiliation":[{"name":"Microbial and Biome Sciences Group (B-IOME), Bioscience Division, Los Alamos National Laboratory","place":["Los Alamos, NM, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[{"name":"Microbial and Biome Sciences Group (B-IOME), Bioscience Division, Los Alamos National Laboratory","place":["Los Alamos, NM, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.copbio.2020.02.016","article-title":"Engineering probiotics for therapeutic applications: recent examples and translational outlook","volume":"65","author":"Aggarwal","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gastro\/goac063","article-title":"Surgery for Crohn\u2019s disease: upfront or last resort","volume":"10","author":"Ahmed Ali","year":"2022","journal-title":"Gastroenterol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1109\/RBME.2019.2908940","article-title":"Therapeutic systems and technologies: state-of-the-art applications, opportunities, and challenges","volume":"13","author":"Almekkawy","year":"2020","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1086\/320518","article-title":"Probiotic agents and infectious diseases: A modern perspective on a traditional therapy","volume":"32","author":"Alvarez-Olmos","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-81-322-2680-2_4","article-title":"Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases","volume-title":"Biology of C reactive protein in health and disease","author":"Ansar","year":"2016"},{"key":"B7","doi-asserted-by":"crossref","first-page":"61195","DOI":"10.3390\/jcm14176119","article-title":"Emerging therapies in inflammatory bowel disease: A comprehensive review","volume":"14","author":"Appiah","year":"2025","journal-title":"J. Clin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1021\/sb3000595","article-title":"Engineered E. coli That Detect and Respond to Gut Inflammation through Nitric Oxide Sensing","volume":"1","author":"Archer","year":"2012","journal-title":"ACS Synth. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jphotobiol.2019.02.005","article-title":"Capping of silver nanoparticles by anti-inflammatory ligands: Antibacterial activity and superoxide anion generation","volume":"193","author":"Az\u00f3car","year":"2019","journal-title":"J. Photochem. Photobiol. B: Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/IJN.S123062","article-title":"Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Ball","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114466","article-title":"Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles","volume":"389","author":"Barros","year":"2026","journal-title":"J. Controlled Release"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s13197-012-0899-1","article-title":"Genetically modified foods: safety, risks and public concerns-a review","volume":"50","author":"Bawa","year":"2013","journal-title":"J. Food Sci. Technol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/molecules25010112","article-title":"The history of nanoscience and nanotechnology: from chemical\u2013physical applications to nanomedicine","volume":"25","author":"Bayda","year":"2020","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"35205","DOI":"10.1038\/s41598-023-30444-y","article-title":"Zinc oxide nanoparticles induce oxidative stress, genotoxicity, and apoptosis in the hemocytes of Bombyx mori larvae","volume":"13","author":"Belal","year":"2023","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/EBC20150001","article-title":"Introduction to biosensors","volume":"60","author":"Bhalla","year":"2016","journal-title":"Essays Biochem."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2023.100257","article-title":"Biosensors and their widespread impact on human health","volume":"5","author":"Bhatia","year":"2024","journal-title":"Sens. Int."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5888\/pcd17.200130","article-title":"Prevalence of multiple chronic conditions among US adults 2018","volume":"17","author":"Boersma","year":"2020","journal-title":"Prev. Chronic Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nphoton.2012.266","article-title":"Plasmonics for future biosensors","volume":"6","author":"Brolo","year":"2012","journal-title":"Nat. Photonics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13905","DOI":"10.1038\/s41467-021-21740-0","article-title":"Applications, challenges, and needs for employing synthetic biology beyond the lab","volume":"12","author":"Brooks","year":"2021","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ijmm.2016.02.010","article-title":"Dysbiosis in intestinal inflammation: Cause or consequence","volume":"306","author":"Butt\u00f3","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14040822","article-title":"Plant-derived exosomes as a drug-delivery approach for the treatment of inflammatory bowel disease and colitis-associated cancer","volume":"14","author":"Cai","year":"2022","journal-title":"Pharmaceutics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2013.11.020","article-title":"Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation","volume":"40","author":"Campbell","year":"2014","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","article-title":"Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis","volume":"18","author":"Cao","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nmeth.3339","article-title":"Quantifying cellular capacity identifies gene expression designs with reduced burden","volume":"12","author":"Ceroni","year":"2015","journal-title":"Nat. Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0958-1669(02)00282-3","article-title":"Luminescent quantum dots for multiplexed biological detection and imaging","volume":"13","author":"Chan","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.759668","article-title":"Surgical management of small bowel crohn\u2019s disease","volume":"9","author":"Chandrasinghe","year":"2022","journal-title":"Front. Surg."},{"key":"B29","volume-title":"Research on the use of probiotics in the prevention and treatment of inflammatory bowel disease","author":"Chen","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.actbio.2025.04.016","article-title":"Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases","volume":"198","author":"Chen","year":"2025","journal-title":"Acta Biomater."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.124933","article-title":"Challenges and strategies faced in the electrochemical biosensing analysis of neurochemicals in vivo: A review","volume":"266","author":"Chen","year":"2024","journal-title":"Talanta"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121956","article-title":"Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish","volume":"329","author":"Chen","year":"2023","journal-title":"Life Sci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100543","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","volume":"18","author":"Chen","year":"2023","journal-title":"Mater. Today Bio"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101782","article-title":"Nanomaterials in the diagnosis and treatment of gastrointestinal tumors: New clinical choices and treatment strategies","volume":"32","author":"Chen","year":"2025","journal-title":"Mater. Today Bio"},{"key":"B30","doi-asserted-by":"publisher","first-page":"31214","DOI":"10.1021\/acsami.3c04408","article-title":"Reductase-labile peptidic supramolecular hydrogels aided in oral delivery of probiotics","volume":"15","author":"Chen","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1186\/s40168-021-01071-4","article-title":"A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota","volume":"9","author":"Chung","year":"2021","journal-title":"Microbiome"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1187831","article-title":"Intestinal bacteria\u2014a powerful weapon for fungal infections treatment","volume":"13","author":"Cong","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e00589","DOI":"10.1128\/iai.00589-21","article-title":"The age of next-generation therapeutic-microbe discovery: exploiting microbe-microbe and host-microbe interactions for disease prevention","volume":"90","author":"Cruz","year":"2022","journal-title":"Infect. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","article-title":"Regulatory considerations, challenges and risk-based approach in nanomedicine development","volume":"28","author":"Cs\u00f3ka","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"21058325","DOI":"10.1002\/smll.202105832","article-title":"Mechanistic studies of an automated lipid nanoparticle reveal critical pharmaceutical properties associated with enhanced mRNA functional delivery in vitro and in vivo","volume":"18","author":"Cui","year":"2022","journal-title":"Small"},{"key":"B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of crohn disease: A review","volume":"325","author":"Cushing","year":"2021","journal-title":"JAMA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"289ra84","DOI":"10.1126\/scitranslmed.aaa3519","article-title":"Programmable probiotics for detection of cancer in urine","volume":"7","author":"Danino","year":"2015","journal-title":"Sci. Trans. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","article-title":"Nanoparticles for oral delivery: Design, evaluation and state-of-the-art","volume":"240","author":"Date","year":"2016","journal-title":"J. Controlled Release"},{"key":"B43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3399\/bjgp16X684433","article-title":"The dangers of NSAIDs: look both ways","volume":"66","author":"Davis","year":"2016","journal-title":"Br. J. Gen. Pract."},{"key":"B44","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jbm.a.36305","article-title":"Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases","volume":"106","author":"Davoudi","year":"2018","journal-title":"J. BioMed. Mater. Res. A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/bit.28574","article-title":"Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases","volume":"121","author":"Debnath","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"B45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1574-6968.2006.00250.x","article-title":"Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid","volume":"259","author":"De Keersmaecker","year":"2006","journal-title":"FEMS Microbiol. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"26685","DOI":"10.3390\/nu16162668","article-title":"Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis","volume":"16","author":"Deleu","year":"2024","journal-title":"Nutrients"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3126280","article-title":"Synergic interaction of rifaximin and mutaflor (Escherichia coli nissle 1917) in the treatment of acetic acid-induced colitis in rats","volume":"2016","author":"Dembi\u0144ski","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"B49","doi-asserted-by":"publisher","first-page":"0531","DOI":"10.1016\/j.exger.2006.10.010","article-title":"Treatment of chronic inflammatory diseases with biologic agents: opportunities and risks for the elderly","volume":"41","author":"Diaz-Borjon","year":"2009","journal-title":"Experimental Gerontology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes","volume":"13","author":"Dri","year":"2023","journal-title":"Drug Delivery Transl. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s43088-023-00361-0","article-title":"A review article of inflammatory bowel disease treatment and pharmacogenomics","volume":"12","author":"Eltantawy","year":"2023","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"49395","DOI":"10.1038\/s41598-018-23180-1","article-title":"Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP","volume":"8","author":"Fang","year":"2018","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1186\/s12951-022-01517-3","article-title":"Nanotechnology for research and treatment of the intestine","volume":"20","author":"Fei","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106925","article-title":"PEG-PLGA nanoparticles transport across in vitro intestinal epithelial models and show potential for oral delivery of antibodies in inflammatory bowel disease","volume":"108","author":"Feng","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4315\/0362-028X.JFP-18-303","article-title":"Inhibitory effect of lactic acid bacteria on foodborne pathogens: A review","volume":"82","author":"Gao","year":"2019","journal-title":"J. Food Prot."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112703","article-title":"Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019\u20132020","volume":"171","author":"Garg","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"B59","volume-title":"Probiotics in the treatment of irritable bowel syndrome","author":"Garn\u00e5s","year":"2016"},{"key":"B60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13099-025-00692-6","article-title":"The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn\u2019s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Gr\u00f8nb\u00e6k","year":"2025","journal-title":"Gut Pathog."},{"key":"B61","doi-asserted-by":"publisher","first-page":"13504","DOI":"10.1021\/acs.nanolett.4c02699","article-title":"Intracellularly gelated macrophages loaded with probiotics for therapy of colitis","volume":"24","author":"Gu","year":"2024","journal-title":"Nano Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.150711","article-title":"Innovative probiotic Escherichia coli nissle 1917-derived outer membrane vesicles coupled microspheres demonstrate anti-inflammatory and barrier-enhancing properties in colitis","volume":"487","author":"Han","year":"2024","journal-title":"Chem. Eng. J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbt.2025.02.003","article-title":"Efficient surface display of single-chain variable fragments against tumor necrosis factor \u03b1 on engineered probiotic Saccharomyces boulardii and its application in alleviating intestinal inflammation in vivo","volume":"86","author":"Han","year":"2025","journal-title":"New Biotechnol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777147","article-title":"Effect of extracellular vesicles derived from lactobacillus plantarum Q7 on gut microbiota and ulcerative colitis in mice","volume":"12","author":"Hao","year":"2021","journal-title":"Front. Immunol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/307519","article-title":"Recent advances in application of biosensors in tissue engineering","volume":"2014","author":"Hasan","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101694","article-title":"Recent advances of nanotechnology application in autoimmune diseases \u2013 A bibliometric analysis","volume":"48","author":"He","year":"2023","journal-title":"Nano Today"},{"key":"B68","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s13036-019-0189-9","article-title":"Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy","volume":"13","author":"He","year":"2019","journal-title":"J. Biol. Eng."},{"key":"B70","doi-asserted-by":"publisher","first-page":"37845","DOI":"10.1038\/s41467-024-48128-0","article-title":"Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis","volume":"15","author":"Heavey","year":"2024","journal-title":"Nat. Commun."},{"key":"B71","volume-title":"Lactobacillus reuteri ATCC PTA 4659 in ulcerative colitis (COLUS)","author":"Hellstr\u00f6m","year":"2019"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01588","article-title":"In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni\u2019s Invasion and Intracellular Survival in Human Colonic Cells","volume":"8","author":"Helmy","year":"2017","journal-title":"Front. Microbiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"51435","DOI":"10.3390\/s24165143","article-title":"Innovations in biosensor technologies for healthcare diagnostics and therapeutic drug monitoring: applications, recent progress, and future research challenges","volume":"24","author":"Hemdan","year":"2024","journal-title":"Sensors"},{"key":"B74","volume-title":"How Inflammatory Biomarkers Help You and Your Doctor Manage Inflammation Biomarkers are a measurable way to treat inflammatory disorders","author":"Hickman","year":"2024"},{"key":"B76","doi-asserted-by":"publisher","first-page":"13845","DOI":"10.3390\/diagnostics14131384","article-title":"Diagnostic procedures for inflammatory bowel disease: laboratory, endoscopy, pathology, imaging, and beyond","volume":"14","author":"Hong","year":"2024","journal-title":"Diagnostics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1073\/pnas.0503125102","article-title":"Targeting quantum dots to surface proteins in living cells with biotin ligase","volume":"102","author":"Howarth","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1186\/s12866-020-01953-x","article-title":"Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages","volume":"20","author":"Hu","year":"2020","journal-title":"BMC Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduction Targeted Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"34715","DOI":"10.1038\/s41467-023-38850-6","article-title":"Modelling genetic stability in engineered cell populations","volume":"14","author":"Ingram","year":"2023","journal-title":"Nat. Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00464-022-09758-x","article-title":"Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons","volume":"37","author":"Irani","year":"2023","journal-title":"Surg. Endoscopy"},{"key":"B83","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.trsl.2012.01.001","article-title":"Biomarkers in inflammatory bowel disease: current practices and recent advances","volume":"159","author":"Iskandar","year":"2012","journal-title":"Trans. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1159\/000333307","article-title":"Escherichia coli Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium","volume":"29","author":"Jacobi","year":"2011","journal-title":"Digestive Dis."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1523052","article-title":"Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00334","article-title":"Unraveling the differences between gram-positive and gram-negative probiotics in modulating protective immunity to enteric infections","volume":"8","author":"Kandasamy","year":"2017","journal-title":"Front. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.4049\/jimmunol.1501705","article-title":"Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity","volume":"196","author":"Kandasamy","year":"2016","journal-title":"J. Immunol."},{"key":"B88","volume-title":"Treatment of ulcerative colitis with a combination of lactobacillus rhamnosus and lactobacillus acidophilus","author":"Klinge","year":"2006"},{"key":"B89","volume-title":"Treatment with lactobacillus rhamnosus and lactobacillus acidophilus for patients with active colonic crohn\u2019s disease","author":"Klinge","year":"2006"},{"key":"B90","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nantod.2012.12.004","article-title":"Theranostic agents for intracellular gene delivery with spatiotemporal imaging","volume":"8","author":"Knipe","year":"2013","journal-title":"Nano Today"},{"key":"B91","volume-title":"Efficacy and safety of E.Coli nissle 1917 in patients with mild (Stage 1-2) or minimal hepatic encephalopathy","author":"Kobyliak","year":"2021"},{"key":"B92","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/diseases8030033","article-title":"The microbiome as a therapeutic target for multiple sclerosis: can genetically engineered probiotics treat the disease","volume":"8","author":"Kohl","year":"2020","journal-title":"Diseases"},{"key":"B93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/rb\/rbw011","article-title":"Critical questions in development of targeted nanoparticle therapeutics","volume":"3","author":"Korsmeyer","year":"2016","journal-title":"Regener. Biomater."},{"key":"B94","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12602-021-09884-3","article-title":"Anti-rotavirus properties and mechanisms of selected gram-positive and gram-negative probiotics on polarized human colonic (HT-29) cells","volume":"15","author":"Kumar","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.16.4","article-title":"Bioengineered probiotics as a new hope for health and diseases: an overview of potential and","volume":"11","author":"Kumar","year":"2016","journal-title":"Future Microbiology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/meg.0000000000000304","article-title":"Diverticular disease as a chronic gastrointestinal condition: experience from a specialist clinic","volume":"27","author":"Kvasnovsky","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820913210","article-title":"Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort","volume":"13","author":"Lahat","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1021\/acs.bioconjchem.5b00607","article-title":"Transforming nanomedicines from lab scale production to novel clinical modality","volume":"27","author":"Landesman-Milo","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.bad-0020-2017","article-title":"Engineering diagnostic and therapeutic gut bacteria","volume":"5","author":"Landry","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"B100","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1053\/j.gastro.2009.11.003","article-title":"Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model","volume":"138","author":"Laroui","year":"2010","journal-title":"Gastroenterology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.dld.2013.03.019","article-title":"Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders","volume":"45","author":"Laroui","year":"2013","journal-title":"Digestive Liver Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","article-title":"The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease","volume":"140","author":"Lewis","year":"2011","journal-title":"Gastroenterology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1013952","article-title":"Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder","volume":"12","author":"Li","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"35443","DOI":"10.1021\/acsnano.4c12801","article-title":"Rewiring Tryptophan Metabolism via Programmable Probiotic Integrated by Dual-Layered Microcapsule Protects against Inflammatory Bowel Disease in Mice","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122584","article-title":"Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery","volume":"309","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B107","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11274-022-03452-9","article-title":"Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice","volume":"39","author":"Liang","year":"2022","journal-title":"World J. Microbiol. Biotechnol."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2544689","article-title":"Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems","volume":"32","author":"Lin","year":"2025","journal-title":"Drug Delivery"},{"key":"B109","volume-title":"Probiotics to treat \u201cInflammatory depression\u201d","author":"Lindqvist","year":"2023"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.707615","article-title":"Grand challenges in biosensors and biomolecular electronics","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00109-020-01987-8","article-title":"Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide","volume":"98","author":"Liu","year":"2020","journal-title":"J. Mol. Med."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.34133\/bdr.0017","article-title":"CRISPR-cas-based engineering of probiotics","volume":"5","author":"Liu","year":"2023","journal-title":"Biodes. Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.131273","article-title":"Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.7150\/thno.91394","article-title":"Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"B110","doi-asserted-by":"publisher","first-page":"7920","DOI":"10.1021\/acs.jafc.4c13017","article-title":"\u201cShield\u201d Armed programmable probiotics harboring \u03b1-aminoadipate aminotransferase gene regulate tryptophan metabolism and gut microbiota to alleviate the inflammatory bowel disease","volume":"73","author":"Liu","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e202502588","DOI":"10.1002\/anie.202502588","article-title":"Engineered probiotics enable targeted gut delivery of dual gasotransmitters for inflammatory bowel disease therapy","volume":"64","author":"Ma","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"B118","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1186\/s12934-022-01799-0","article-title":"Engineered probiotics","volume":"21","author":"Ma","year":"2022","journal-title":"Microb. Cell Fact."},{"key":"B120","doi-asserted-by":"crossref","DOI":"10.1520\/JAI13110","volume-title":"Nanotechnology--An introduction for the standards community","author":"Mansoori","year":"2005"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.4254\/wjh.v14.i3.634","article-title":"Effect of a specific Escherichia coli Nissle 1917 strain on minimal\/mild hepatic encephalopathy treatment","volume":"14","author":"Manzhalii","year":"2000","journal-title":"World Journal of Hepatology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2020.105064","article-title":"A comparison of EU and US consumers\u2019 willingness to pay for gene-edited food: Evidence from apples","volume":"159","author":"Marette","year":"2021","journal-title":"Appetite"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9676452","article-title":"The prospects for the therapeutic implications of genetically engineered probiotics","volume":"2020","author":"Mazhar","year":"2020","journal-title":"J. Food Qual."},{"key":"B124","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.addr.2016.04.032","article-title":"Microbiome therapeutics \u2014 Advances and challenges","volume":"105","author":"Mimee","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/15376516.2010.547887","article-title":"Amelioration of experimental colitis by a novel nanoselenium\u2013silymarin mixture","volume":"21","author":"Miroliaee","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signaling"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1111\/codi.16271","article-title":"Distinct changes in the colonic microbiome associated with acute diverticulitis","volume":"24","author":"MJ","year":"2022","journal-title":"Colorectal Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"10187","DOI":"10.1021\/acsnano.0c03457","article-title":"Dextran-coated cerium oxide nanoparticles: A computed tomography contrast agent for imaging the gastrointestinal tract and inflammatory bowel disease","volume":"14","author":"Naha","year":"2020","journal-title":"ACS Nano"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41587-021-00950-3","article-title":"Wearable materials with embedded synthetic biology sensors for biomolecule detection","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.091108","article-title":"Guidelines for management of patients with a short bowel","author":"Nightingale","year":"2006"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/liv.14815","article-title":"Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile-duct ligated rats","volume":"41","author":"Ochoa-Sanchez","year":"2021","journal-title":"Liver Int."},{"key":"B132","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1038\/s41392-025-02516-0","article-title":"Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel disease","volume":"10","author":"Oh","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"key":"B133","doi-asserted-by":"publisher","first-page":"36085","DOI":"10.3390\/diagnostics13243608","article-title":"Landscape of innovative methods for early diagnosis of gastric cancer: A systematic review","volume":"13","author":"Or\u0103\u015feanu","year":"2023","journal-title":"Diagnostics"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms232314905","article-title":"What exactly is inflammation (and what is it not)","volume":"23","author":"Oronsky","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gut.2003.025403","article-title":"Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease","volume":"53","author":"Ott","year":"2004","journal-title":"Gut"},{"key":"B136","volume-title":"Impact of additional treatment with saccharomyces boulardii on quality of life in patients with mild forms of ulcerative colitis and crohn disease","author":"Panic","year":"2019"},{"key":"B138","volume-title":"Additive effect of probiotics (Mutaflor","author":"Park","year":"2021"},{"key":"B139","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3904\/kjim.2021.458","article-title":"Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis FAU - Park, Soo-Kyung FAU - Kang, Sang-Bum FAU - Kim, SangSoo FAU - Kim, Tae Oh FAU - Cha, Jae Myung FAU - Im, Jong Pil FAU - Choi, Chang Hwan FAU - Kim, Eun Soo FAU - Seo, Geom Seog FAU - Eun, Chang Soo FAU - Han, Dong Soo FAU - Park, Dong Il","volume":"37","author":"Park","year":"2022","journal-title":"Korean J. Intern. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3904\/kjim.2021.458","article-title":"Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis \u201c","volume":"37","author":"Park","year":"2022","journal-title":"Korean J. Intern. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"478","DOI":"10.5217\/ir.2021.00121","article-title":"Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model","volume":"19","author":"Park","year":"2021","journal-title":"Intest. Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpge.2015.07.004","article-title":"Biopsies in gastrointestinal endoscopy: when and how","volume":"23","author":"Peixoto","year":"2016","journal-title":"GE Portuguese J. Gastroenterol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"54665","DOI":"10.3390\/ijms23105466","article-title":"Next-generation probiotics for inflammatory bowel disease","volume":"23","author":"Pesce","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B144","article-title":"E. Coli nissle","volume-title":"Treatment of ulcerative colitis with ciprofloxacin and","author":"Petersen","year":"2013"},{"key":"B145","volume-title":"The effects of bifidobacterium breve bif195 for small intestinal crohn\u2019s disease","author":"Petersen","year":"2023"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.crohns.2014.06.001","article-title":"Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial","volume":"8","author":"Petersen","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1186\/1471-2180-9-171","article-title":"A phylogenetic group of Escherichia coli associated with active left-sided Inflammatory Bowel Disease","volume":"9","author":"Petersen","year":"2009","journal-title":"BMC Microbiol."},{"key":"B147","volume-title":"The BEGIN study bifidobacterium infantis to newborns: effects of modulating the gut microbial composition on growth, immune function and inflammatory conditions - a randomized placebo-controlled double-blinded intervention trial (BEGIN)","author":"Philipsen","year":"2024"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2217\/nnm-2017-0043","article-title":"Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies","volume":"12","author":"Pietersz","year":"2017","journal-title":"Nanomedicine"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.biomaterials.2005.11.018","article-title":"Advances in fluorescence imaging with quantum dot bio-probes","volume":"27","author":"Pinaud","year":"2006","journal-title":"Biomaterials"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mbio.01470-20","article-title":"Probiotic properties of escherichia coli nissle in human intestinal organoids","volume":"11","author":"Pradhan","year":"2020","journal-title":"mBio"},{"key":"B151","doi-asserted-by":"publisher","first-page":"55805","DOI":"10.1038\/s41467-019-13336-6","article-title":"Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut","volume":"10","author":"Praveschotinunt","year":"2019","journal-title":"Nat. Commun."},{"key":"B152","doi-asserted-by":"publisher","first-page":"76825","DOI":"10.1038\/s41467-025-63037-6","article-title":"Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles","volume":"16","author":"Qassem","year":"2025","journal-title":"Nat. Commun."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/bit.28972","article-title":"Engineered lactobacillus rhamnosus producing 3-hydroxybutyrate: A dual-action therapeutic strategy for colon cancer cachexia","volume":"122","author":"Qiu","year":"2025","journal-title":"Biotechnol. Bioeng."},{"key":"B154","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.mpmed.2021.08.002","article-title":"Bacterial gastroenteritis","volume":"49","author":"Ranasinghe","year":"2021","journal-title":"Medicine"},{"key":"B155","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13765-017-0285-9","article-title":"Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review","volume":"60","author":"Ranneh","year":"2017","journal-title":"Appl. Biol. Chem."},{"key":"B156","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1039\/D5NA00632E","article-title":"Influence of coprecipitation synthesis parameters on the physicochemical properties and biological effects of iron oxide nanoparticles","volume":"7","author":"Reindl","year":"2025","journal-title":"Nanoscale Adv."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s10620-006-9622-2","article-title":"Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause","volume":"52","author":"Rezaie","year":"2007","journal-title":"Digestive Dis. Sci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nbt.3879","article-title":"Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation","volume":"35","author":"Riglar","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/AEM.03224-13","article-title":"Quorum-Sensing Regulation of Constitutive Plantaricin by Lactobacillus plantarum Strains under a Model System for Vegetables and Fruits","volume":"80","author":"Rizzello","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.fochx.2021.100196","article-title":"Bioactive peptides produced by engineered probiotics and other food-grade bacteria: A review","volume":"13","author":"Romero-Luna","year":"2022","journal-title":"Food Chem.: X"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories,1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3748\/wjg.v29.i14.2078","article-title":"Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives","volume":"29","author":"Roy","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"7935","DOI":"10.3390\/microorganisms11030793","article-title":"Anti-quorum sensing activity of probiotics: the mechanism and role in food and gut health","volume":"11","author":"Salman","year":"2023","journal-title":"Microorganisms"},{"key":"B165","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000342742","article-title":"The future of inflammatory bowel disease therapy: where do we go from here","volume":"30","author":"Sandborn","year":"2013","journal-title":"Digestive Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/0091270007301623","article-title":"The role of TNF\u03b1 in ulcerative colitis","volume":"47","author":"Sands","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"15995","DOI":"10.3390\/microorganisms9081599","article-title":"Current and future antiviral strategies to tackle gastrointestinal viral infections","volume":"9","author":"Santos-Ferreira","year":"2021","journal-title":"Microorganisms"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3748\/wjg.v22.i24.5505","article-title":"Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update","volume":"22","author":"Scaldaferri","year":"2016","journal-title":"World Journal of Gastroenterology"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-021-01390-x","article-title":"Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease","volume":"27","author":"Scott","year":"2021","journal-title":"Nat. Med."},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01096","article-title":"Oral administration of the probiotic strain escherichia coli nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction","volume":"8","author":"Secher","year":"2017","journal-title":"Front. Immunol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1007\/s13346-024-01736-1","article-title":"Dual action tofacitinib-loaded PLGA nanoparticles alleviate colitis in an IBD mouse model","volume":"15","author":"Seegobin","year":"2025","journal-title":"Drug Delivery Transl. Res."},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2020.129062","article-title":"Highly selective SPR based fiber optic sensor for the detection of hydrogen peroxide","volume":"329","author":"Semwal","year":"2021","journal-title":"Sens. Actuators B: Chem."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/bios10090127","article-title":"Recent advances in portable biosensors for biomarker detection in body fluids","volume":"10","author":"Senf","year":"2020","journal-title":"Biosensors"},{"key":"B174","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/are.13006","article-title":"Identification and partial characterization of potential probiotic lactic acid bacteria in freshwater Labeo rohita and Cirrhinus mrigala","volume":"48","author":"Shahid","year":"2017","journal-title":"Aquacult. Res."},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104344","article-title":"Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications","volume":"148","author":"Shamoon","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B177","doi-asserted-by":"publisher","first-page":"19095565","DOI":"10.1002\/adfm.201909556","article-title":"Recent advances in smart biomaterials for the detection and treatment of autoimmune diseases","volume":"30","author":"Shodeinde","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"B178","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1586\/14737159.2014.888313","article-title":"Advances and challenges in biosensor-based diagnosis of infectious diseases","volume":"14","author":"Sin","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B179","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11468-011-9206-7","article-title":"Refractive index sensitivity analysis of ag, au, and cu nanoparticles","volume":"6","author":"Singh Sekhon","year":"2011","journal-title":"Plasmonics"},{"key":"B180","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1754-1611-4-12","article-title":"Designing and engineering evolutionary robust genetic circuits","volume":"4","author":"Sleight","year":"2010","journal-title":"J. Biol. Eng."},{"key":"B181","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1021\/sb400055h","article-title":"Visualization of evolutionary stability dynamics and competitive fitness of escherichia coli engineered with randomized multigene circuits","volume":"2","author":"Sleight","year":"2013","journal-title":"ACS Synth. Biol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbi.2025.06.002","article-title":"Add-on probiotics for inflammatory depression \u2013 A double-blind randomized placebo-controlled trial","volume":"129","author":"S\u00f6derberg Veib\u00e4ck","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"B183","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/08910600903444267","article-title":"The non-pathogenic Escherichia coli strain Nissle 1917 \u2013 features of a versatile probiotic","volume":"21","author":"Sonnenborn","year":"2009","journal-title":"Microb. Ecol. Health Dis."},{"key":"B184","volume-title":"Probiotic after acute colonic diverticulitis","author":"Spaziani","year":"2023"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1515\/ntrev-2024-0057","article-title":"Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease","volume":"13","author":"Stojanov","year":"2024","journal-title":"Nanotechnol. Rev."},{"key":"B187","volume-title":"Viral gastroenteritis (Nursing)","author":"Stuempfig","year":"2025"},{"key":"B188","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1021\/acsami.4c18134","article-title":"Harnessing akkermansia muciniphila membrane coating for probiotic therapy in inflammatory bowel disease","volume":"17","author":"Su","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B189","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat. Med."},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777665","article-title":"Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121707","article-title":"Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis","volume":"288","author":"Sung","year":"2022","journal-title":"Biomaterials"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of america 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"79","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121709","article-title":"Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice","volume":"324","author":"Tang","year":"2023","journal-title":"Life Sci."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.819336","article-title":"Probiotic escherichia coli nissle 1917 expressing elafin protects against inflammation and restores the gut microbiota","volume":"13","author":"Teng","year":"2022","journal-title":"Front. Microbiol."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosx.2022.100232","article-title":"Biosensors for cancer theranostics","volume":"12","author":"Thenrajan","year":"2022","journal-title":"Biosens. Bioelectron.: X"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3748\/wjg.v21.i1.21","article-title":"Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives","volume":"21","author":"Tontini","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.4240\/wjgs.v16.i5.1235","article-title":"Surgical treatment of inflammatory bowel disease: From the gastroenterologist\u2019s stand-point","volume":"16","author":"Triantafillidis","year":"2024","journal-title":"World Journal of Gastrointestinal Surgery"},{"key":"B200","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cels.2023.05.004","article-title":"Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden","volume":"14","author":"Triassi","year":"2023","journal-title":"Cell Syst."},{"key":"B201","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-018-0493-6","article-title":"Probiotics, prebiotics and amelioration of diseases","volume":"26","author":"Tsai","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"147995","DOI":"10.3390\/ijms232314799","article-title":"Microbiota composition in diverticular disease: implications for therapy","volume":"23","author":"Tursi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B203","first-page":"18","article-title":"Challenges in biosensor development: Detection limit, detection time, and specificity","volume":"16","author":"Varshney","year":"2009","journal-title":"Resour.: Eng. Technol. Sustain. World"},{"key":"B204","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1186\/1471-2164-12-316","article-title":"Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease","volume":"12","author":"Vejborg","year":"2011","journal-title":"BMC Genomics"},{"key":"B205","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/antibiotics9020059","article-title":"Bacterial biofilm and its role in the pathogenesis of disease","volume":"9","author":"Vestby","year":"2020","journal-title":"Antibiotics"},{"key":"B206","doi-asserted-by":"publisher","first-page":"22736155","DOI":"10.1080\/13814788.2023.2273615","article-title":"Direct-to-patient digital diagnostics in primary care: Opportunities, challenges, and conditions necessary for responsible digital diagnostics","volume":"29","author":"Villalobos-Quesada","year":"2023","journal-title":"Eur. J. Gen. Pract."},{"key":"B207","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/eji.201646498","article-title":"Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses","volume":"46","author":"Vlasova","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100679","article-title":"Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis","volume":"20","author":"Wang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"B210","doi-asserted-by":"publisher","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B209","doi-asserted-by":"publisher","first-page":"e102195","DOI":"10.1002\/btm2.10219","article-title":"An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae\/butyrate\/retinoic acid axis","volume":"6","author":"Wang","year":"2021","journal-title":"Bioeng. Trans. Med."},{"key":"B211","doi-asserted-by":"publisher","first-page":"17001975","DOI":"10.1002\/smtd.201700197","article-title":"Construction of plasmonic nano-biosensor-based devices for point-of-care testing","volume":"1","author":"Wang","year":"2017","journal-title":"Small Methods"},{"key":"B212","doi-asserted-by":"publisher","first-page":"e4705","DOI":"10.3399\/bjgp19X704321","article-title":"Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink","volume":"69","author":"Watson","year":"2019","journal-title":"Br. J. Gen. Pract."},{"key":"B213","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1021\/acssynbio.4c00036","article-title":"Engineering a novel probiotic toolkit in escherichia coli nissle 1917 for sensing and mitigating gut inflammatory diseases","volume":"13","author":"Weibel","year":"2024","journal-title":"ACS Synth. Biol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature09415","article-title":"Gut inflammation provides a respiratory electron acceptor for Salmonella","volume":"467","author":"Winter","year":"2010","journal-title":"Nature"},{"key":"B215","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14336\/ad.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis."},{"key":"B216","doi-asserted-by":"publisher","first-page":"23165755","DOI":"10.1080\/19490976.2024.2316575","article-title":"A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation","volume":"16","author":"Wu","year":"2024","journal-title":"Gut Microbes"},{"key":"B218","doi-asserted-by":"publisher","first-page":"e01651","DOI":"10.1128\/spectrum.01651-22","article-title":"Probiotics (Lactobacillus plantarum HNU082) supplementation relieves ulcerative colitis by affecting intestinal barrier functions, immunity-related gene expression, gut microbiota, and metabolic pathways in mice","volume":"10","author":"Wu","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1021\/jacs.8b09397","article-title":"Challenges and solutions in developing ultrasensitive biosensors","volume":"141","author":"Wu","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"B219","doi-asserted-by":"publisher","first-page":"22078905","DOI":"10.1002\/adma.202207890","article-title":"Probiotic-inspired nanomedicine restores intestinal homeostasis in colitis by regulating redox balance, immune responses, and the gut microbiome","volume":"35","author":"Xu","year":"2023","journal-title":"Adv. Mater."},{"key":"B220","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1038\/s41423-021-00760-2","article-title":"Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis","volume":"18","author":"Yan","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1021\/acsnano.1c09681","article-title":"Physiologically inspired mucin coated escherichia coli nissle 1917 enhances biotherapy by regulating the pathological microenvironment to improve intestinal colonization","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"B221","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1186\/s12889-025-24009-z","article-title":"From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Public Health"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/acs.nanolett.3c03580","article-title":"Microfluidics-derived microparticles with prebiotics and probiotics for enhanced in situ colonization and immunoregulation of colitis","volume":"24","author":"Yin","year":"2024","journal-title":"Nano Lett."},{"key":"B224","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41522-024-00563-z","article-title":"Protection against DSS-induced colitis in mice through Fc\u03f5RI\u03b1 deficiency: the role of altered Lactobacillus","volume":"10","author":"Yin","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.125166","article-title":"Nononcogenic restoration of the intestinal barrier by E. coli\u2013delivered human EGF","volume":"4","author":"Yu","year":"2019","journal-title":"JCI Insight"},{"key":"B226","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.2147\/ijn.S413141","article-title":"Application of nanoparticles in the diagnosis of gastrointestinal diseases: A complete future perspective","volume":"18","author":"Yue","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ibd\/izy123","article-title":"Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Inflammatory Bowel Dis."},{"key":"B228","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1128\/AEM.01390-12","article-title":"Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin Protein","volume":"78","author":"Zhang","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"111262","DOI":"10.1016\/j.cclet.2025.111262","article-title":"Nanotechnology-based natural remedies: Advancing inflammatory bowel disease treatment through targeted drug delivery","author":"Zhao","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"B229","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1039\/D2TB00300G","article-title":"Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis","volume":"10","author":"Zhao","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"B231","doi-asserted-by":"publisher","first-page":"47225","DOI":"10.3390\/nu15224722","article-title":"Effect of extracelluar vesicles derived from akkermansia muciniphila on intestinal barrier in colitis mice","volume":"15","author":"Zheng","year":"2023","journal-title":"Nutrients"},{"key":"B234","volume-title":"Efficacy and safety of orally administered engineered probiotics (CBT102-A) for the treatment of children with phenylketonuria","author":"Zhou","year":"2023"},{"key":"B235","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12934-020-01318-z","article-title":"Engineering probiotics as living diagnostics and therapeutics for improving human health","volume":"19","author":"Zhou","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"B232","doi-asserted-by":"publisher","first-page":"34325","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"B233","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41522-024-00479-8","article-title":"Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer","volume":"10","author":"Zhou","year":"2024","journal-title":"NPJ Biofilms Microbiomes"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1762119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:58:24Z","timestamp":1772607504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1762119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":226,"alternative-id":["10.3389\/fcimb.2026.1762119"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1762119","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1762119"}}